id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zGuiMq0oEemRwZ8I8DF1XA,jgraPEon,https://europepmc.org/articles/PMC4294342/,methylthioadenosine phosphorylase,nning the potential inactivated , (MTAP) that exhibited homozygou,TextQuoteSelector,TextPositionSelector,10919,10952,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:03:54.609593+00:00
yEQ2Yq0mEemv_TcownsCpA,jgraPEon,https://europepmc.org/articles/PMC4294342/,mice ,combined immunodeficient (SCID) ,(BioLasco) and allowed to grow u,TextQuoteSelector,TextPositionSelector,51834,51839,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:49:28.737687+00:00
y7o3ErQJEemAY7dnIzOOEA,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP as a functional tumor ,nd clinical evidence reinforces ,suppressor gene exhibiting progn,TextQuoteSelector,TextPositionSelector,14651,14678,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:09:37.394256+00:00
x6xnZK0nEemoZXN5gaFRpA,jgraPEon,https://europepmc.org/articles/PMC4294342/,MMP-2,e reported to increase secreted , in vitro to enhance matrix degr,TextQuoteSelector,TextPositionSelector,42380,42385,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:56:37.331852+00:00
x2ixjrQJEemHh5tS8PDJfA,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor",4342PMID: 25426549Downregulated ," suppressive function, and thera",TextQuoteSelector,TextPositionSelector,6523,6612,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:09:30.168530+00:00
wpXpPq0oEemQj7PEXSFlVA,jgraPEon,https://europepmc.org/articles/PMC4294342/,lentivirus,lls were incubated with 8 mL of ," in the presence of polybrene, f",TextQuoteSelector,TextPositionSelector,49091,49101,MIS_OG,yes,[MIS_OG][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:03:38.446050+00:00
vrYsBK0mEem_34ujhNo6ig,jgraPEon,https://europepmc.org/articles/PMC4294342/,luciferase," After 48h, the cells underwent ", assays by using a dual lucifera,TextQuoteSelector,TextPositionSelector,48495,48505,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:49:12.765031+00:00
vo120LQJEemKsyMqghfn5g,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP-deficient hepatocellular carcinomas,erant inactivating mechanism in ," [21]. Functionally, MTAP reexpr",TextQuoteSelector,TextPositionSelector,38152,38192,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:09:15.214490+00:00
vVyQsq0oEemZoK_Ca6QWfw,jgraPEon,https://europepmc.org/articles/PMC4294342/, Ki-67,"ling of cyclin D1, cyclin E, and",", as well as decreased intratumo",TextQuoteSelector,TextPositionSelector,30892,30898,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:03:29.688501+00:00
v1OJJq0nEemPmF-5g-v0kg,jgraPEon,https://europepmc.org/articles/PMC4294342/,ornithine decarboxylase,inine metabolism may upregulate , (ODC) and subsequently induce o,TextQuoteSelector,TextPositionSelector,41950,41973,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:56:23.353460+00:00
uJTLHq0mEemX_lsMfFlqyA,jgraPEon,https://europepmc.org/articles/PMC4294342/,cyclin E,", cyclin D1 (1:100, Epitomics), "," (1:20, Abcam), Ki-67 (1:200, ab",TextQuoteSelector,TextPositionSelector,46024,46032,WS_GP,yes,[WS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:49:02.417559+00:00
uC1kPK0nEeml_xdPGgEoDg,jgraPEon,https://europepmc.org/articles/PMC4294342/,T-cell lymphomas,", they were prone to developing ","; however, homozygous inactivati",TextQuoteSelector,TextPositionSelector,38494,38510,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:56:11.463963+00:00
tnxG2LQJEemAYocEs5WrDw,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP-positive tumor,"tissue microarray sections, the ", cells only ranged from 10% to 2,TextQuoteSelector,TextPositionSelector,36840,36859,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:09:01.776779+00:00
t3QCFq0oEemqdhOAkBfxYQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,cyclin-dependent kinases,and G1/S-associated cyclins and ,". Among these, only cyclin D1 ex",TextQuoteSelector,TextPositionSelector,25012,25036,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:03:19.518999+00:00
sLP5TrQJEempyUshxZkxRg,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP reexpression caused decreased susceptibility to L-alanosine in the OH931 (middle) and NMFH-2 (right) cells. (C) The average tumor ,"arent lines and empty controls, ",volume was significantly larger ,TextQuoteSelector,TextPositionSelector,32256,32391,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:08:52.088262+00:00
rDQ_grQJEemjwDc5ZONVgw,jgraPEon,https://europepmc.org/articles/PMC4294342/, MTAP on tumor ,The in vivo inhibitory effect of,growth was analyzed in NMFH-2 xe,TextQuoteSelector,TextPositionSelector,30154,30169,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:08:44.532026+00:00
r0aVeK0nEemwAJOxatQPyQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumorigenicity,-independent growth and in vivo , [9]. Although mice heterozygous,TextQuoteSelector,TextPositionSelector,38320,38334,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:55:56.528179+00:00
qQufbq0nEemZg0s1w1RAcw,jgraPEon,https://europepmc.org/articles/PMC4294342/,gliomas ,non-small cell lung cancers and ,"[13, 14, 23–26]. Instead of geno",TextQuoteSelector,TextPositionSelector,38020,38028,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:55:45.968394+00:00
pH6O8LQJEemE44NvHmvpCw,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP is linked to polyamine metabolism and adenine and methionine salvage [16, 17], examining whether MTAP inactivation promotes angiogenesis by perturbing the metabolic balance of sarcoma",myxofibrosarcomas [15]. Because ," cells is conceivable, similar t",TextQuoteSelector,TextPositionSelector,26628,26816,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:08:31.506452+00:00
oyPj2K0lEemodLvFvTjkdw,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP ,4342PMID: 25426549Downregulated ,expression in myxofibrosarcoma: ,TextQuoteSelector,TextPositionSelector,6523,6528,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:41:16.914374+00:00
olO-Dq0nEem4CSMol7RsVw,jgraPEon,https://europepmc.org/articles/PMC4294342/,non-small cell lung cancers,the loss of adjoining CDKN2A in ," and gliomas [13, 14, 23–26]. In",TextQuoteSelector,TextPositionSelector,37988,38015,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:55:34.800270+00:00
nmCzkLQJEem-oQOcXRM1TQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumors were not homozygously deleted at the MTAP ,f the 29 MTAP protein-deficient ,"gene (Table ​(Table1),1), methyl",TextQuoteSelector,TextPositionSelector,17696,17745,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:08:21.409067+00:00
mf9NzK0nEemxrleI1ILBYA,jgraPEon,https://europepmc.org/articles/PMC4294342/,malignancies,letion is not uncommon in human , and is primarily attributable t,TextQuoteSelector,TextPositionSelector,37838,37850,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:55:20.516521+00:00
laRjRrQJEem_OnddebpxIQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP) on 9p21.3 because whether the tumor,hylthioadenosine phosphorylase (,-suppressive role of this polyam,TextQuoteSelector,TextPositionSelector,13936,13977,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:08:06.783028+00:00
lExVTK0mEemodxsfY44nvw,jgraPEon,https://europepmc.org/articles/PMC4294342/,cancer, progression involving multiple ," hallmarks [16, 30]. For instanc",TextQuoteSelector,TextPositionSelector,42286,42292,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:48:01.386436+00:00
ktaxUq0nEemj1-NnKfEWcw,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumor progression,ively late genetic event in the ,", which may confer survival adva",TextQuoteSelector,TextPositionSelector,37641,37658,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:55:08.724095+00:00
jQEL-q0oEemZhnuDOIP64g,jgraPEon,https://europepmc.org/articles/PMC4294342/,CD31 ,umoral vessels stained with the ,"endothelial marker, substantiati",TextQuoteSelector,TextPositionSelector,30959,30964,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:02:08.307716+00:00
jOkthrQJEem771u-jGOeGw,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP expression on tumor,sine. The inhibiting effects of ," growth, angiogenesis, and the i",TextQuoteSelector,TextPositionSelector,12130,12154,NGD,no,NGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:07:52.139294+00:00
jNaUSK0nEemm9qvJjDO6UQ,jgraPEon,https://europepmc.org/articles/PMC4294342/, tumorigenesis, early phase of myxofibrosarcoma,". However, MTAP homozygous delet",TextQuoteSelector,TextPositionSelector,37541,37555,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:54:58.672477+00:00
jKvzBq0mEem9-DOjiBCwVw,jgraPEon,https://europepmc.org/articles/PMC4294342/, cancer,s with aggressiveness in various," types [15, 28]. Kiroviski repor",TextQuoteSelector,TextPositionSelector,41037,41044,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:47:48.865643+00:00
hxKRWq0oEemague-DMBMsw,jgraPEon,https://europepmc.org/articles/PMC4294342/,argininosuccinate synthetase , reported that aberrant loss of ,(ASS1) caused by promoter methyl,TextQuoteSelector,TextPositionSelector,26482,26511,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:01:58.609144+00:00
h1CweK0qEemiXq8mBPyrog,jgraPEon,https://europepmc.org/articles/PMC4294342/,LacZ,lls transduced with shMTAP or sh,.Enzyme-linked immunosorbent ass,TextQuoteSelector,TextPositionSelector,50493,50497,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:16:17.869545+00:00
gwoi3K0mEemT3f_RN-IFng,jgraPEon,https://europepmc.org/articles/PMC4294342/,ASS1, the antiangiogenic function of ,", a rate-limiting enzyme convert",TextQuoteSelector,TextPositionSelector,41662,41666,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:47:32.625479+00:00
fV3rVq0nEemK6MN0S-J10g,jgraPEon,https://europepmc.org/articles/PMC4294342/,annexin V,"FH-2 cells, was validated using ",/propidium iodide staining assay,TextQuoteSelector,TextPositionSelector,34416,34425,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:54:32.834988+00:00
fOLxQK0mEem99i-dQ2m_lw,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumors,"omas, MTAP-homozygously deleted ", were often high-grade and clini,TextQuoteSelector,TextPositionSelector,37188,37194,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:47:22.329583+00:00
dzjXmq0nEemwX-fHnQM8oQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,CDK2, in alterations in cyclin E and , expression varied between exoge,TextQuoteSelector,TextPositionSelector,25257,25261,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:54:22.290438+00:00
dL97bq0mEemnfLsAKP-PTg,jgraPEon,https://europepmc.org/articles/PMC4294342/,sarcoma,eficient high-grade pleomorphic , cells that exhibit frequent mit,TextQuoteSelector,TextPositionSelector,31600,31607,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:47:08.765337+00:00
cjNBXK0pEemZjA-HPozaGA,jgraPEon,https://europepmc.org/articles/PMC4294342/,Animal ,ptosis assays in Methods-S5-S11.,xenograftsThe animal use committ,TextQuoteSelector,TextPositionSelector,51514,51521,MIS_OG,yes,[MIS_OG][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:08:32.942093+00:00
cTsjIK0nEem9_fMjpYcbjQ,jgraPEon,https://europepmc.org/articles/PMC4294342/, cyclins,s in the G1- and G1/S-associated, and cyclin-dependent kinases. A,TextQuoteSelector,TextPositionSelector,24999,25007,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:54:12.336713+00:00
cDL5hK0oEem4BmviypnauA,jgraPEon,https://europepmc.org/articles/PMC4294342/,S3A,against endogenous MTAP (Figure ,",C). According to matrigel invas",TextQuoteSelector,TextPositionSelector,26171,26174,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:01:20.193326+00:00
agiAUq0nEemXYGtdaY5QpQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,MATP,"3A, S1A). Therefore, we applied ",-bearing vectors and shMTAP to d,TextQuoteSelector,TextPositionSelector,22118,22122,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:54:00.191766+00:00
aP1F6q0mEeml6zeg-6l0Jg,jgraPEon,https://europepmc.org/articles/PMC4294342/,protein deficiency,ed apoptotic cells (right).MTAP , was associated with increases o,TextQuoteSelector,TextPositionSelector,32975,32993,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:46:49.028040+00:00
_Xjo3rQJEem47IvL8ldnnA,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumor volume of the empty vector-transfected NMFH-2 xenografts was significantly larger than that of the MTAP,myxofibrosarcoma(A) The average ,-reexpressing counterparts (left,TextQuoteSelector,TextPositionSelector,31227,31336,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:00.848844+00:00
_C5RIq0oEemZid_sysmTKA,jgraPEon,https://europepmc.org/articles/PMC4294342/,oncogenes ,CDK6 and MET on 7q as amplified ,of pathogenic relevance [6–8]. R,TextQuoteSelector,TextPositionSelector,13621,13631,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:05:14.943886+00:00
YyQCKq0nEeml7U_1mQO7kQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,carcinogenesis, that may independently inhibit ," [9, 11]. We first characterized",TextQuoteSelector,TextPositionSelector,21545,21559,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:53:48.714282+00:00
Ycc19q0mEeml6jMaQW91gw,jgraPEon,https://europepmc.org/articles/PMC4294342/,cyclin D1,of MTAP linked to downregulated ,(A) Compared with reference CCD9,TextQuoteSelector,TextPositionSelector,22608,22617,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:46:36.835204+00:00
YNXpnLRnEem1b-8UMgSXXw,jgraPEon,https://europepmc.org/articles/PMC4294342/, S1B," mitotic rate (P = 0.011, Figure","), and marginally correlated wit",TextQuoteSelector,TextPositionSelector,18511,18515,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T14:19:30.829241+00:00
WsQ3BK0mEemZ1pM1Svb5WA,jgraPEon,https://europepmc.org/articles/PMC4294342/,Tumor ,s did not differ prognostically.,suppressive functions of MTAP in,TextQuoteSelector,TextPositionSelector,21208,21214,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:46:25.002757+00:00
Wb_pVq0nEemYA887pfjgxw,jgraPEon,https://europepmc.org/articles/PMC4294342/,Tumor necrosis,08 Extremity23421545 Axial913514,0.4830.115 <10%19384110 >=10%131,TextQuoteSelector,TextPositionSelector,18934,18948,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:53:32.917365+00:00
Vk1DIK0pEemwCa9aXYzVoQ,jgraPEon,https://europepmc.org/articles/PMC4294342/, transcriptional factor,metastasis.Because MTAP is not a,", it is conceivable to hypothesi",TextQuoteSelector,TextPositionSelector,41439,41462,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:07:46.261099+00:00
TfEyCq0oEem4BTNWelDvlQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,S3B,ed invading tumor cells (Figure ,"), indicating enhanced metastati",TextQuoteSelector,TextPositionSelector,26301,26304,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:00:22.717881+00:00
T6nYqq0nEemT32NHP-qWPQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,PFKL, homozygous deletion at an MTAP/," ratio of < 0.2 (Table ​(Table1,",TextQuoteSelector,TextPositionSelector,17590,17594,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:53:15.848444+00:00
RtvFxq0nEemZo6sA_z-2xg,jgraPEon,https://europepmc.org/articles/PMC4294342/,nonneoplastic, of the MTAP gene. Intratumoral , cells in MFS96b account for the,TextQuoteSelector,TextPositionSelector,16775,16788,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:53:01.351600+00:00
R_3qwq0pEemRwo8CwnwEfQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,breast cancer ,AP reexpression in MTAP-deleted ,cells may inhibit anchorage-inde,TextQuoteSelector,TextPositionSelector,38247,38261,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:07:22.084643+00:00
RYjeiLRnEembVhORCyE3Cg,jgraPEon,https://europepmc.org/articles/PMC4294342/,S1A,"promoter (Figure ​(Figure3A,3A, ","). Therefore, we applied MATP-be",TextQuoteSelector,TextPositionSelector,22078,22081,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T14:18:44.924793+00:00
Q5tFBK0mEeml-Tsv_mDqvg,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumor,rate windowFigure 4MTAP governs , angiogenesis by the transcripti,TextQuoteSelector,TextPositionSelector,28606,28611,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:45:46.296654+00:00
P1a-FK0nEemafqtkWB3iOg,jgraPEon,https://europepmc.org/articles/PMC4294342/,CDK6 ,nd characterized SKP2 on 5p and ,and MET on 7q as amplified oncog,TextQuoteSelector,TextPositionSelector,13589,13594,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:52:48.655312+00:00
OYNJ2q0nEemcLAcFJ92kzA,jgraPEon,https://europepmc.org/articles/PMC4294342/,SKP2 ,nd cell lines and characterized ,on 5p and CDK6 and MET on 7q as ,TextQuoteSelector,TextPositionSelector,13574,13579,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:52:38.963833+00:00
O0sJjK0oEemYB7ew91DPCQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,immunodeficient ,he flanks of 16 severe combined ,(SCID) mice (BioLasco) and allow,TextQuoteSelector,TextPositionSelector,51811,51827,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:59:51.119046+00:00
Nk10-K0mEeml98tmrDqKLw,jgraPEon,https://europepmc.org/articles/PMC4294342/,CXCL-10,"s (Table S5). Of these, CXCL-9, ",", and MMP-9 proteins were concom",TextQuoteSelector,TextPositionSelector,27711,27718,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:45:24.012712+00:00
McyUEq0nEemoe6-LB9CVyw,jgraPEon,https://europepmc.org/articles/PMC4294342/,metastatic diseases,"local recurrence, and may cause "," [1–4]. However, histological ev",TextQuoteSelector,TextPositionSelector,12924,12943,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:52:25.733206+00:00
M5yLKLQKEemzM7NaCAn7zA,jgraPEon,https://europepmc.org/articles/PMC4294342/," MTAP deficiency in myxofibrosarcomas, and particularly that caused by homozygous deletion, negatively affects prognosis. In vitro and in vivo, MTAP may act as a tumor ","ng and AMP synthesis.In summary,","suppressor, serving antiangiogen",TextQuoteSelector,TextPositionSelector,43787,43955,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:12:31.598864+00:00
M3lu2q0mEemZ09NDw_J3IA,jgraPEon,https://europepmc.org/articles/PMC4294342/, CXCL-9,"candidates (Table S5). Of these,",", CXCL-10, and MMP-9 proteins we",TextQuoteSelector,TextPositionSelector,27702,27709,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:45:19.133821+00:00
LdfQWLQKEem47ecXKkbUSQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP-inactivated myxofibrosarcomas renders this aggressive tumor subset a tumor-specific metabolic feature for use in L-alanosine therapy, which targets adenylosuccinate synthetase to abolish de novo AMP synthesis from IMP [13, 14, 30]. In vitro and in vivo, the growth inhibition of MTAP-deficient tumors ", disabled methionine salvage in ,by L-alanosine was partially asc,TextQuoteSelector,TextPositionSelector,42683,42989,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:12:21.998578+00:00
LIbNUK0oEemot3-lq3GN3g,jgraPEon,https://europepmc.org/articles/PMC4294342/,S11, apoptosis assays in Methods-S5-,.Animal xenograftsThe animal use,TextQuoteSelector,TextPositionSelector,51510,51513,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:59:26.594273+00:00
JmvfHLQKEemWJKvo4DP6Zg,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP knockdown upregulated MMP-9 expression through the accumulation of 5′-deoxy-5′-methylthioadenosine in hepatocellular carcinomas,"5, 28]. Kiroviski reported that "," [29]. However, they neither elu",TextQuoteSelector,TextPositionSelector,41085,41217,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:12:09.652483+00:00
JmJXcK0mEem2nN_6kV0gGA,jgraPEon,https://europepmc.org/articles/PMC4294342/,MMP-9," Of these, CXCL-9, CXCL-10, and ", proteins were concomitantly dow,TextQuoteSelector,TextPositionSelector,27724,27729,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:44:57.170892+00:00
JiOYRK0oEemngL-bBOBeFw,jgraPEon,https://europepmc.org/articles/PMC4294342/,viral infection,) using Lipofectamine 2000. For ,", 3 × 106 NMFH-1 cells were incu",TextQuoteSelector,TextPositionSelector,49025,49040,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:59:15.844194+00:00
Jasx3K0pEemS3AOhh4jzKw,jgraPEon,https://europepmc.org/articles/PMC4294342/,collagen ,creased numbers of fibrohyaline ,fibers and TUNEL-labeled apoptot,TextQuoteSelector,TextPositionSelector,32912,32921,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:06:24.424375+00:00
IbI3MrQKEemR9JvikeTIkw,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP-deficient xenografts and myxofibrosarcoma specimens, MMP-9 overexpression was present in the tumor ", myxofibrosarcoma cells. In the ,cells and extracellular stroma a,TextQuoteSelector,TextPositionSelector,40683,40787,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:12:01.611427+00:00
IGknEq0nEemK5ceXPOKTdw,jgraPEon,https://europepmc.org/articles/PMC4294342/,hepatocellular carcinomas ,deoxy-5′-methylthioadenosine in ,"[29]. However, they neither eluc",TextQuoteSelector,TextPositionSelector,41192,41218,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:51:56.855512+00:00
HmzTEK0mEemm8Bedvz0MuA,jgraPEon,https://europepmc.org/articles/PMC4294342/,myxofibrosarcomas,sion and gene status in primary ,MTAP Expression (n=87)p-valueMTA,TextQuoteSelector,TextPositionSelector,18704,18721,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:44:43.570298+00:00
H7yuqq0oEemZPmu2n_xc5g,jgraPEon,https://europepmc.org/articles/PMC4294342/,Viruses ,an National RNAi Core Facility. ,were produced by transfecting HE,TextQuoteSelector,TextPositionSelector,48758,48766,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:59:04.795271+00:00
GbESSq0nEemZ2n_nP8HQ8Q,jgraPEon,https://europepmc.org/articles/PMC4294342/,defects ,caused by alternative molecular ,such as small deletions of 5′ re,TextQuoteSelector,TextPositionSelector,36515,36523,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:51:45.210589+00:00
GSZNvK0oEema9o9X1-lkTQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,Arcturus, using the Veritas LCM machine (,) to extract genomic DNA. The MT,TextQuoteSelector,TextPositionSelector,46643,46651,WT_OG,no,[WT_OG],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:58:54.138270+00:00
G17gkrQKEemjnbOMqMmf_w,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP as a functional suppressor that governs myxofibrosarcoma pathogenesis by inhibiting tumor ,indings corroborated endogenous ,"proliferation, metastasis, and a",TextQuoteSelector,TextPositionSelector,40309,40404,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:51.020348+00:00
FO0D3q0pEem_6LsAkECArA,jgraPEon,https://europepmc.org/articles/PMC4294342/,polyamine metabolism-regulating enzyme , tumor-suppressive role of this ,is independent from the frequent,TextQuoteSelector,TextPositionSelector,14003,14042,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:05:56.595661+00:00
F6cFxLQKEem8sD86WlxEOg,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP in metastasis, which is the leading cause of sarcoma",borated the suppressive role of ,-associated mortality and critic,TextQuoteSelector,TextPositionSelector,39486,39543,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:44.763830+00:00
Ez3i5rQKEemPtV-RJQEWAw,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP deficiency in myxofibrosarcomas, we characterized the biology of MTAP expression to clarify its functional effects on cancer ",Given the clinical relevance of ,hallmark-related phenotypes. The,TextQuoteSelector,TextPositionSelector,38771,38901,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:37.424348+00:00
Enh5kK0oEemUK0PU8j7SOg,jgraPEon,https://europepmc.org/articles/PMC4294342/,mantle cell lymphomas ,to be mitochondria-dependent in ,"[24]. In addition, we demonstrat",TextQuoteSelector,TextPositionSelector,43186,43208,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:58:42.881567+00:00
E0ssQq0nEemUKA8UqK69MQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,p21,he middle deletion core (9p22.2-,".1), homozygous deletions freque",TextQuoteSelector,TextPositionSelector,16302,16305,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:51:34.734298+00:00
ChLLMK0nEemQinv9AKC3zw,jgraPEon,https://europepmc.org/articles/PMC4294342/,CDKN2B ,"ssion, in which MTAP and CDKN2A/",were homozygously deleted in 4 a,TextQuoteSelector,TextPositionSelector,15923,15930,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:51:19.392784+00:00
CK-P-rQKEemyzH_1a5HUHg,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP-hypermethylated and MTAP-expressing myxofibrosarcomas, MTAP-homozygously deleted tumors",pared with the equally indolent , were often high-grade and clini,TextQuoteSelector,TextPositionSelector,37102,37194,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:19.604127+00:00
C-_doLQKEemE5AMIlPgdQw,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP homozygous deletion represents a relatively late genetic event in the tumor ,"sarcoma tumorigenesis. However, ","progression, which may confer su",TextQuoteSelector,TextPositionSelector,37566,37647,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:25.086302+00:00
BcUJtLQKEemGMw9stRf1Ig,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP-reexpressing group (lower panel), which exhibited low-grade MTAP-expressing spindle cells (right). (B) L-alanosine effectively attenuated the viability of MTAP-deficient NMFH-2 and OH931 myxofibrosarcoma cell lines, and MTAP-expressing NMFH-1 cells were relatively resistant to L-alanosine, demonstrating >50% viable sarcoma",ng results were observed in the ," cells, even at 100 μM (left). U",TextQuoteSelector,TextPositionSelector,31833,32162,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:14.742191+00:00
AYBgxq0oEemZpcfY2VrcBg,jgraPEon,https://europepmc.org/articles/PMC4294342/,Annexin-V ,hich was evidenced by increased ,and TUNEL labeling in myxofibros,TextQuoteSelector,TextPositionSelector,43091,43101,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:58:14.246672+00:00
AQnw1q0nEemJPy-ZFHvhnA,jgraPEon,https://europepmc.org/articles/PMC4294342/,Myc , a pCMV6 control or a pMTAP-DDK-,vector into myxofibrosarcoma cel,TextQuoteSelector,TextPositionSelector,48419,48423,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:51:03.991968+00:00
AJjnHLQKEemlOPszTRBPqA,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP-deficient high-grade pleomorphic sarcoma,nografts (upper panel) comprise , cells that exhibit frequent mit,TextQuoteSelector,TextPositionSelector,31562,31607,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:11:06.105788+00:00
9gUcOrQJEem5rS_3OpReLQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP exhibited a significantly small average tumor ,A). The xenografts reexpressing ,volume from Day 7 until sacrific,TextQuoteSelector,TextPositionSelector,30322,30373,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:48.469376+00:00
88AIhrQJEemkSBO3CL9kbA,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP reexpression inhibited growth of xenografted tumors,ults are expressed as mean ± SD.,The in vivo inhibitory effect of,TextQuoteSelector,TextPositionSelector,30066,30122,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:44.485560+00:00
78ttarQJEem78Kc7xF-5hA,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP governs tumor angiogenesis by the transcriptional repression of MMP-9,pen in a separate windowFigure 4,(A) The well-formed HUVEC tubes ,TextQuoteSelector,TextPositionSelector,28593,28667,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:38.006739+00:00
77g5pq0lEemopr_-h8T4gA,jgraPEon,https://europepmc.org/articles/PMC4294342/,Myxofibrosarcoma ,"n, methylationGo to:INTRODUCTION",is characterized by the multinod,TextQuoteSelector,TextPositionSelector,12622,12639,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:43:25.391394+00:00
65uAhrQJEemR8_tvknd-Zw,jgraPEon,https://europepmc.org/articles/PMC4294342/," tumor cells (Figure S3B), indicating enhanced metastatic propensity by MTAP",significantly increased invading, deficiency in myxofibrosarcomas,TextQuoteSelector,TextPositionSelector,26280,26356,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:30.893256+00:00
5wyp3LQJEemtG6ueANBT4Q,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP modulates myxofibrosarcoma phenotypes regarding various cancer,TAP to decipher how inactivated , hallmarks. The stably transfect,TextQuoteSelector,TextPositionSelector,22178,22245,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:23.233690+00:00
50p82K0mEemZf2MbA4xA3A,jgraPEon,https://europepmc.org/articles/PMC4294342/,ODC,ikely mediated by overexpressed ,", which converges growth-promoti",TextQuoteSelector,TextPositionSelector,42560,42563,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:50:20.412750+00:00
4wAoaK0lEem96jNZXubtiA,jgraPEon,https://europepmc.org/articles/PMC4294342/,myxofibrosarcoma ,close-up view of representative ,cell line (NMFH-2) and tissue (M,TextQuoteSelector,TextPositionSelector,16650,16667,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:43:04.001354+00:00
4dQu9LQJEemaR18AuZrA1A,jgraPEon,https://europepmc.org/articles/PMC4294342/,Tumor suppressive functions of MTAP,s did not differ prognostically., in myxofibrosarcomaBecause of p,TextQuoteSelector,TextPositionSelector,21208,21243,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:14.605895+00:00
4-L8DLQJEem0DbvsYphP6Q,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumor-suppressive attributes of MTAP,olars have started noticing the , that may independently inhibit ,TextQuoteSelector,TextPositionSelector,21477,21513,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:18.059069+00:00
3scYmq0nEemS16NjS-njNw,jgraPEon,https://europepmc.org/articles/PMC4294342/, IMP,olish de novo AMP synthesis from," [13, 14, 30]. In vitro and in v",TextQuoteSelector,TextPositionSelector,42901,42905,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:57:16.159078+00:00
3FDZyK0pEem2s9fD6Bp2ZA,jgraPEon,https://europepmc.org/articles/PMC4294342/,tumor suppressor gene,mpting the search for potential ,(s) underlying this selection pr,TextQuoteSelector,TextPositionSelector,13804,13825,"WT_DS,GP",yes,[WT_DS][GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:11:30.893871+00:00
3EzOvrQJEem-oz9kZt_Oew,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP-deficient tumors ,"homozygously deleted cases, the ",caused by methylation exhibited ,TextQuoteSelector,TextPositionSelector,20334,20356,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:05.319848+00:00
30IdIK0mEemYAIdutklxmw,jgraPEon,https://europepmc.org/articles/PMC4294342/,PIK3R1 ,to detect the MTAP gene dosage. ,(5q13.1) was the reference gene ,TextQuoteSelector,TextPositionSelector,46367,46374,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:50:07.237805+00:00
2g9buq0mEemafUtB_gidQg,jgraPEon,https://europepmc.org/articles/PMC4294342/,CDKN2A,r without the loss of adjoining , in non-small cell lung cancers ,TextQuoteSelector,TextPositionSelector,37978,37984,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:49:58.582667+00:00
1s561q0lEemZOY-oCg-GFg,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP ,not homozygously deleted at the ,"gene (Table ​(Table1),1), methyl",TextQuoteSelector,TextPositionSelector,17740,17745,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:42:43.536308+00:00
1isN6q0nEem9_4NrcDm3Pw,jgraPEon,https://europepmc.org/articles/PMC4294342/,adenylosuccinate synthetase,"lanosine therapy, which targets ", to abolish de novo AMP synthesi,TextQuoteSelector,TextPositionSelector,42836,42863,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:57:01.304466+00:00
18tN1LQJEemLTh954G5NRQ,jgraPEon,https://europepmc.org/articles/PMC4294342/,"MTAP protein expression and promoter methylation, no significant difference was detected in the clincopathological features, including the tumor ",lation. Regarding the status of ,grading and staging. By contrast,TextQuoteSelector,TextPositionSelector,18168,18313,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:09:57.685814+00:00
0z_VTK0oEemof6sKstDKQA,jgraPEon,https://europepmc.org/articles/PMC4294342/,TUNEL,ibrohyaline collagen fibers and ,-labeled apoptotic cells (right),TextQuoteSelector,TextPositionSelector,32932,32937,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:04:06.271306+00:00
0R3ZPK0mEem2obcNS_s8cg,jgraPEon,https://europepmc.org/articles/PMC4294342/,human,"CD966SK dermal fibroblasts, and ", umbilical venous endothelial ce,TextQuoteSelector,TextPositionSelector,47448,47453,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:49:43.539554+00:00
0FRa-rQJEemZj2-PUw57kg,jgraPEon,https://europepmc.org/articles/PMC4294342/,MTAP-deficient sarcoma, hematoxylin-eosin (left) shows , cells (middle) and the nondetec,TextQuoteSelector,TextPositionSelector,17136,17158,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:09:44.941488+00:00
-gcuLLQJEem8FIfPQiiOfw,jgraPEon,https://europepmc.org/articles/PMC4294342/, tumor suppressive function of MTAP,a separate windowFigure 5In vivo, and the inhibition of L-alanosi,TextQuoteSelector,TextPositionSelector,31107,31142,YGD,no,YGD,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-08-01T03:10:54.797235+00:00
-fh2Hq0mEemRu1cWg8znWA,jgraPEon,https://europepmc.org/articles/PMC4294342/,DDK,Cells stably expressing MTAP or ,-Myc tags alone were selected us,TextQuoteSelector,TextPositionSelector,48142,48145,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:50:52.056545+00:00
-LoasK0lEemxqedVOZQBqw,jgraPEon,https://europepmc.org/articles/PMC4294342/,myxofibrosarcomas ,ages are frequently observed in ,"after local recurrence, and may ",TextQuoteSelector,TextPositionSelector,12868,12886,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T08:43:40.368775+00:00
-DXTEK0oEemouxMfaLIOKw,jgraPEon,https://europepmc.org/articles/PMC4294342/,MET,terized SKP2 on 5p and CDK6 and , on 7q as amplified oncogenes of,TextQuoteSelector,TextPositionSelector,13598,13601,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,"Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.",2019-07-23T09:05:08.300058+00:00
